The 24 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 125.00, with a high estimate of 135.00 and a low estimate of 103.00. The median estimate represents a +18.06% increase from the last price of 105.88.
The current consensus among 29 polled investment analysts is to Buy stock in Merck & Co Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.96
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.